Top Markets
Coin of the day
Crossject Société Anonyme Crossject Société Anonyme

Crossject Société Anonyme

ALCJ
Rank in Stocks #12744
Crossject Société Anonyme develops needle-free injection systems. The company... Crossject Société Anonyme develops needle-free injection systems. The company develops ZENEO, a needle-free, prefilled, and single-use auto-injector. Its clinical stage drugs comprise Sumatriptan, which is used for of treatment migraines and cluster headaches; Adrenaline for treating anaphylactic shock; Hydrocortisone that is used for treatment of acute adrenal crisis; Midazolam for treating epileptic seizure; Naloxone used for treatment of overdose; Apomorphine, for treating temporary paralysis in parkinson's disease; Methotrexate used for treatment of rheumatoid arthritis; and Terbutaline, for treating severe asthma crisis. The company was founded in 1997 and is based in Dijon, France.
Share Price
$2.02
Market Cap
$121.30M
Change (1 day)
-1.04%
Change (1 year)
-2.09%
Country
FR
Trade Crossject Société Anonyme (ALCJ)

Category

Number of shares outstanding for Crossject Société Anonyme (ALCJ)
Number of shares outstanding as of December 2025: 52.26M
According to Crossject Société Anonyme latest financial reports and stock price the company's current number of shares outstanding is 52.26M. At the end of December 2023 the company had 37.09M shares outstanding. The number of outstanding shares is usually impacted by stock plits and shares buy back.
Shares outstanding history for Crossject Société Anonyme (ALCJ) from 2010 to 2026
Shares Outstanding at the end of each year
Year Shares Outstanding Change
2026 (TTM) 52.26M 15.51%
2024 45.24M 21.99%
2023 37.09M 2.00%
2022 36.36M 39.81%
2021 26.01M 8.11%
2020 24.06M 19.51%
2019 20.13M 47.92%
2018 13.61M 47.92%
2017 9.20M 21.62%
2016 7.56M 7.89%
2015 7.01M 5.42%
2014 6.65M 25.86%
2013 5.28M 19.22%
2012 4.43M 0.00%
2011 4.43M 0.00%
2010 4.43M 0.00%
Shares Outstanding for similar companies or competitors
Company Shares Outstanding Difference Country
354.90M 579.08%
US
463.21M 786.33%
FR
345.26M 560.64%
DE
336.65M 544.17%
JP
280.64M 436.99%
US